Health-Related Quality of Life and Cardiovascular Disease Risk in Korean Adults
0
조회
0
다운로드
11
인용
0
참고문헌
키워드
초록
Background: Health-related quality of life (HRQoL) is considered an important outcome measure in chronic diseases, in particular cardiovascular disease (CVD), which is known to be associated with impaired HRQoL. However, few studies have examined HRQoL in individuals at high risk of CVD. Methods: Using the Fifth Korea National Health and Nutrition Examination Survey 2010–2012, we analyzed data from 10,307 adults aged ≥30 years. The study subjects were stratified into 3 groups on the basis of their Framingham risk score—a 10-year estimate of CVD risk: <10.0% (low risk), 10.0%–19.9% (moderate risk), and ≥20.0% (high risk). The EuroQol-5D (EQ-5D) was used to evaluate HRQoL. Results: A significantly higher proportion of high-risk subjects than low-risk participants had impaired HRQoL (defined as the lowest quartile of the EQ-5D index); this held true even after adjustment for confounding factors in multivariable logistic regression analysis (men: odds ratio [OR], 1.62; 95% confidence interval [CI], 1.24–2.11; women: OR, 1.46; 95% CI, 1.02–2.08). In terms of the 5 EQ-5D dimensions, a 10-year CVD risk ≥20.0% was significantly associated with self-reported problems of mobility in men (OR, 3.15; 95% CI, 2.02–4.90), and of mobility (OR, 1.56; 95% CI, 1.09–2.24), self-care (OR, 2.14; 95% CI, 1.09–4.22), and usual activity problems (OR, 1.80; 95% CI, 1.17–2.78) in women. Conclusion: A high CVD risk is associated with impaired HRQoL. After adjustment for demographic and clinical factors, a 10-year CVD risk ≥20.0% is an independent predictor of impaired HRQoL in the general population; in particular, of mobility problems in men, and of mobility, self-care, and usual activity problems in women.
Abstract
Background: Health-related quality of life (HRQoL) is considered an important outcome measure in chronic diseases, in particular cardiovascular disease (CVD), which is known to be associated with impaired HRQoL. However, few studies have examined HRQoL in individuals at high risk of CVD. Methods: Using the Fifth Korea National Health and Nutrition Examination Survey 2010–2012, we analyzed data from 10,307 adults aged ≥30 years. The study subjects were stratified into 3 groups on the basis of their Framingham risk score—a 10-year estimate of CVD risk: <10.0% (low risk), 10.0%–19.9% (moderate risk), and ≥20.0% (high risk). The EuroQol-5D (EQ-5D) was used to evaluate HRQoL. Results: A significantly higher proportion of high-risk subjects than low-risk participants had impaired HRQoL (defined as the lowest quartile of the EQ-5D index); this held true even after adjustment for confounding factors in multivariable logistic regression analysis (men: odds ratio [OR], 1.62; 95% confidence interval [CI], 1.24–2.11; women: OR, 1.46; 95% CI, 1.02–2.08). In terms of the 5 EQ-5D dimensions, a 10-year CVD risk ≥20.0% was significantly associated with self-reported problems of mobility in men (OR, 3.15; 95% CI, 2.02–4.90), and of mobility (OR, 1.56; 95% CI, 1.09–2.24), self-care (OR, 2.14; 95% CI, 1.09–4.22), and usual activity problems (OR, 1.80; 95% CI, 1.17–2.78) in women. Conclusion: A high CVD risk is associated with impaired HRQoL. After adjustment for demographic and clinical factors, a 10-year CVD risk ≥20.0% is an independent predictor of impaired HRQoL in the general population; in particular, of mobility problems in men, and of mobility, self-care, and usual activity problems in women.
참고문헌 (30)
- Lozano R, "Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010", Lancet, 380, pp.2095~2128 (2012)
- Alvarez-Bueno C, "Effectiveness of multifactorial interventions in primary health care settings for primary prevention of cardiovascular disease: a systematic review of systematic reviews", Prev Med, 76(Suppl), pp.S68~S75 (2015)
- Cepeda-Valery B, "Measuring health related quality of life in coronary heart disease: the importance of feeling well", Int J Cardiol, 149, pp.4~9 (2011)
- Wenger NK, "Assessment of quality of life in clinical trials of cardiovascular therapies", Am J Cardiol, 54, pp.908~913 (1984)
- Centers for Disease Control and Prevention, "Measuring healthy days:population assessment of health-related quality of life" (2000), Centers for Disease Control and Prevention
- Xie J, "Patient-reported health status in coronary heart disease in the United States: age, sex, racial, and ethnic differences", Circulation, 118, pp.491~497 (2008)
- De Smedt D, "Health related quality of life in coronary patients and its association with their cardiovascular risk profile: results from the EUROASPIRE III survey", Int J Cardiol, 168, pp.898~903 (2013)
- Sullivan PW, "Impact of cardiometabolic risk factor clusters on health-related quality of life in the U.S", Obesity (Silver Spring), 15, pp.511~521 (2007)
- Ludt S, "Predictors of health-related quality of life in patients at risk for cardiovascular disease in European primary care", PLoS One, 6, pp.e29334~ (2011)
- Korea Centers for Disease Control and Prevention, "Korean health statistics 2010: Korea National Health and Nutrition Examination Survey (KNHANES V-1)" (2011), Korea Centers for Disease Control and Prevention
- Korea Centers for Disease Control and Prevention, "Korean health statistics 2011: Korea National Health and Nutrition Examination Survey (KNHANES V-2)" (2012), Korea Centers for Disease Control and Prevention
- Korea Centers for Disease Control and Prevention, "Korean health statistics 2012: Korea National Health and Nutrition Examination Survey (KNHANES V-3)" (2013), Korea Centers for Disease Control and Prevention
- Richardson LC, "Health-related quality of life in cancer survivors between ages 20 and 64 years:population-based estimates from the Behavioral Risk Factor Surveillance System", Cancer, 112, pp.1380~1389 (2008)
- Alonso J, "Health-related quality of life associated with chronic conditions in eight countries: results from the International Quality of Life Assessment (IQOLA) Project", Qual Life Res, 13, pp.283~298 (2004)
- Lee H, "The association of moderate renal dysfunction with impaired preference-based healthrelated quality of life: third Korean national health and nutritional examination survey", BMC Nephrol, 13, pp.19~ (2012)
- D’Agostino RB Sr, "General cardiovascular risk profile for use in primary care:the Framingham Heart Study", Circulation, 117, pp.743~753 (2008)
- Rabin R, "EQ-5D: a measure of health status from the EuroQol Group", Ann Med, 33, pp.337~343 (2001)
- Nam H, "EQ-5D Korean valuation study using time trade of method" (2007), Korea Centers for Disease Control and Prevention
- Blumel JE, "Quality of life after the menopause: a population study", Maturitas, 34, pp.17~23 (2000)
- Jiang Y, "Associations between health-related quality of life and demographics and health risks. Results from Rhode Island’s 2002behavioral risk factor survey", Health Qual Life Outcomes, 4, pp.14~ (2006)
- Kaplan GA, "Socioeconomic factors and cardiovascular disease:a review of the literature", Circulation, 88(4 Pt 1), pp.1973~1998 (1993)
- Govil SR, "Socioeconomic status and improvements in lifestyle, coronary risk factors, and quality of life: the Multisite Cardiac Lifestyle Intervention Program", Am J Public Health, 99, pp.1263~1270 (2009)
- Bromberger JT, "Psychologic distress and natural menopause: a multiethnic community study", Am J Public Health, 91, pp.1435~1442 (2001)
- Trevisol DJ, "Health-related quality of life and hypertension: a systematic review and meta-analysis of observational studies", J Hypertens, 29, pp.179~188 (2011)
- Rubin RR, "Quality of life and diabetes", Diabetes Metab Res Rev, 15, pp.205~218 (1999)
- Tillmann M, "A comparison of smokers’ and ex-smokers’ healthrelated quality of life", J Public Health Med, 19, pp.268~273 (1997)
- Lalonde L, "Health-related quality of life with coronary heart disease prevention and treatment", J Clin Epidemiol, 54, pp.1011~1018 (2001)
- Lalonde L, "Health-related quality of life in cardiac patients with dyslipidemia and hypertension", Qual Life Res, 13, pp.793~804 (2004)
- Bharmal M, "Comparing the EQ-5D and the SF-6D descriptive systems to assess their ceiling effects in the US general population", Value Health, 9, pp.262~271 (2006)
- Kontodimopoulos N, "Validity of the EuroQoL (EQ-5D) instrument in a Greek general population", Value Health, 11, pp.1162~1169 (2008)